These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 17371258

  • 1. The role of secretory leucoprotease inhibitor in the resolution of inflammatory responses.
    Weldon S, McGarry N, Taggart CC, McElvaney NG.
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):273-6. PubMed ID: 17371258
    [Abstract] [Full Text] [Related]

  • 2. Innate host defense functions of secretory leucoprotease inhibitor.
    Weldon S, Taggart CC.
    Exp Lung Res; 2007 Dec; 33(10):485-91. PubMed ID: 18075823
    [Abstract] [Full Text] [Related]

  • 3. Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family.
    Moreau T, Baranger K, Dadé S, Dallet-Choisy S, Guyot N, Zani ML.
    Biochimie; 2008 Feb; 90(2):284-95. PubMed ID: 17964057
    [Abstract] [Full Text] [Related]

  • 4. SLPI and inflammatory lung disease in females.
    McKiernan PJ, McElvaney NG, Greene CM.
    Biochem Soc Trans; 2011 Oct; 39(5):1421-6. PubMed ID: 21936826
    [Abstract] [Full Text] [Related]

  • 5. Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease.
    Schmid M, Fellermann K, Fritz P, Wiedow O, Stange EF, Wehkamp J.
    J Leukoc Biol; 2007 Apr; 81(4):907-15. PubMed ID: 17200145
    [Abstract] [Full Text] [Related]

  • 6. SLPI and elafin: multifunctional antiproteases of the WFDC family.
    Scott A, Weldon S, Taggart CC.
    Biochem Soc Trans; 2011 Oct; 39(5):1437-40. PubMed ID: 21936829
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. SLPI and elafin: one glove, many fingers.
    Williams SE, Brown TI, Roghanian A, Sallenave JM.
    Clin Sci (Lond); 2006 Jan; 110(1):21-35. PubMed ID: 16336202
    [Abstract] [Full Text] [Related]

  • 9. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing.
    Ashcroft GS, Lei K, Jin W, Longenecker G, Kulkarni AB, Greenwell-Wild T, Hale-Donze H, McGrady G, Song XY, Wahl SM.
    Nat Med; 2000 Oct; 6(10):1147-53. PubMed ID: 11017147
    [Abstract] [Full Text] [Related]

  • 10. Human neutrophil elastase inhibitors in innate and adaptive immunity.
    Fitch PM, Roghanian A, Howie SE, Sallenave JM.
    Biochem Soc Trans; 2006 Apr; 34(Pt 2):279-82. PubMed ID: 16545094
    [Abstract] [Full Text] [Related]

  • 11. SLPI and trappin-2 as therapeutic agents to target airway serine proteases in inflammatory lung diseases: current and future directions.
    Zani ML, Tanga A, Saidi A, Serrano H, Dallet-Choisy S, Baranger K, Moreau T.
    Biochem Soc Trans; 2011 Oct; 39(5):1441-6. PubMed ID: 21936830
    [Abstract] [Full Text] [Related]

  • 12. Secretory leukocyte protease inhibitor (SLPI), a multifunctional protein in the host defense response.
    Majchrzak-Gorecka M, Majewski P, Grygier B, Murzyn K, Cichy J.
    Cytokine Growth Factor Rev; 2016 Apr; 28():79-93. PubMed ID: 26718149
    [Abstract] [Full Text] [Related]

  • 13. Relationship between antimicrobial proteins and airway inflammation and infection in cystic fibrosis.
    Sagel SD, Sontag MK, Accurso FJ.
    Pediatr Pulmonol; 2009 Apr; 44(4):402-9. PubMed ID: 19283840
    [Abstract] [Full Text] [Related]

  • 14. Effect of pro-inflammatory stimuli on mucin expression and inhibition by secretory leucoprotease inhibitor.
    Griffin S, Carroll TP, Greene CM, O'Neill SJ, Taggart CC, McElvaney NG.
    Cell Microbiol; 2007 Mar; 9(3):670-9. PubMed ID: 17026478
    [Abstract] [Full Text] [Related]

  • 15. Secretory leukocyte protease inhibitor and elafin/trappin-2: versatile mucosal antimicrobials and regulators of immunity.
    Sallenave JM.
    Am J Respir Cell Mol Biol; 2010 Jun; 42(6):635-43. PubMed ID: 20395631
    [Abstract] [Full Text] [Related]

  • 16. The alarm anti-protease, secretory leukocyte protease inhibitor, is a proliferation and survival factor for ovarian cancer cells.
    Simpkins FA, Devoogdt NM, Rasool N, Tchabo NE, Alejandro EU, Kamrava MM, Kohn EC.
    Carcinogenesis; 2008 Mar; 29(3):466-72. PubMed ID: 17916899
    [Abstract] [Full Text] [Related]

  • 17. In silico study of whey-acidic-protein domain containing oral protease inhibitors.
    Idoji Y, Watanabe Y, Yamashita A, Yamanishi K, Nishiguchi S, Shimada K, Yasunaga T, Yamanishi H.
    Int J Mol Med; 2008 Apr; 21(4):461-8. PubMed ID: 18360692
    [Abstract] [Full Text] [Related]

  • 18. The Role of Serine Proteases and Antiproteases in the Cystic Fibrosis Lung.
    Twigg MS, Brockbank S, Lowry P, FitzGerald SP, Taggart C, Weldon S.
    Mediators Inflamm; 2015 Apr; 2015():293053. PubMed ID: 26185359
    [Abstract] [Full Text] [Related]

  • 19. Protease-antiprotease imbalances differ between Cystic Fibrosis patients' upper and lower airway secretions.
    Hentschel J, Fischer N, Janhsen WK, Markert UR, Lehmann T, Sonnemann J, Böer K, Pfister W, Hipler UC, Mainz JG.
    J Cyst Fibros; 2015 May; 14(3):324-33. PubMed ID: 25286826
    [Abstract] [Full Text] [Related]

  • 20. WAP domain proteins as modulators of mucosal immunity.
    Wilkinson TS, Roghanian A, Simpson AJ, Sallenave JM.
    Biochem Soc Trans; 2011 Oct; 39(5):1409-15. PubMed ID: 21936824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.